235 related articles for article (PubMed ID: 6762620)
1. [Immunological mechanisms in aplastic anemia. III. Arguments against the role of primary immunologic disorders in aplastic anemia: effect of transfusion of blood components on the course of aplastic anemia].
Rupniewska ZM; Dmoszyńska-Giannopoulos A
Przegl Lek; 1982; 39(12):821-3. PubMed ID: 6762620
[No Abstract] [Full Text] [Related]
2. Difficulties in predicting bone-marrow graft rejection in patients with aplastic anemia.
Elfenbein GJ; Anderson PN; Klein DL; Schacter BZ; Santos GW
Transplant Proc; 1978 Jun; 10(2):441-5. PubMed ID: 150078
[No Abstract] [Full Text] [Related]
3. [Transfusion therapy in the strategy for bone marrow transplantation].
Isacchi G; Cardillo AM; Chiarioni S; Gozzer M; Granati L; Panzini E; Perrone P; Pugliese P; Rosato V; Screnci M
Haematologica; 1991 Jun; 76 Suppl 3():411-9. PubMed ID: 1661269
[No Abstract] [Full Text] [Related]
4. Analysis of factors related to bone marrow graft rejection in aplastic anemia: usefulness of measures of broad alloimmunity as predictors.
Elfenbein G; Kallman C; Braine H; Bias W; Tutschka P; Karp J; Burke P; Wharam M; Saral R; Kaizer H; Mellits E; Santos G
Transplant Proc; 1981 Sep; 13(3):1539-43. PubMed ID: 7029810
[No Abstract] [Full Text] [Related]
5. Immunologic mechanisms in aplastic anemia.
Finlay JL; Ershler WB; Shahidi NT
Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
[TBL] [Abstract][Full Text] [Related]
6. Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
Oldham RK; Simmler MC
Transplant Proc; 1974 Dec; 6(4):417-9. PubMed ID: 4280166
[No Abstract] [Full Text] [Related]
7. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
Livnat S; Seigneuret M; Storb R; Prentice RL
J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
[TBL] [Abstract][Full Text] [Related]
8. [Immunological mechanisms in aplastic anemia. II. Clinical data suggesting the role of immunologic disorders in the etiology of aplastic anemia: studies in vitro].
Rupniewska ZM; Dmoszyńska-Giannopoulos A
Przegl Lek; 1982; 39(10):667-74. PubMed ID: 6218514
[No Abstract] [Full Text] [Related]
9. The biology of graft rejection in a canine model of marrow transplantation.
Storb R; Deeg HJ; Appelbaum FR; Schuening FW; Raff RF; Graham TC
Transplant Proc; 1987 Dec; 19(6 Suppl 7):18-22. PubMed ID: 3321644
[No Abstract] [Full Text] [Related]
10. The detection of non-HLA antibodies and their possible role in bone marrow graft rejection.
Claas FH; van Rood JJ; Warren RP; Weiden PL; Su PJ; Storb R
Transplant Proc; 1979 Mar; 11(1):423-6. PubMed ID: 377669
[No Abstract] [Full Text] [Related]
11. Bone marrow transplantation in aplastic anemia and leukemia.
Hershko C; Gale RP
Transplant Proc; 1980 Dec; 12(4):612-5. PubMed ID: 7010721
[No Abstract] [Full Text] [Related]
12. [Characteristics of splenectomy in patients with hypo- and aplastic anemias].
Slizkov SS; Grozdov DM
Probl Gematol Pereliv Krovi; 1974 Sep; 19(9):37-42. PubMed ID: 4617876
[No Abstract] [Full Text] [Related]
13. Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
Bone Marrow Transplant; 1996 Dec; 18(6):1179-81. PubMed ID: 8971392
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia.
Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
Transplant Proc; 1981 Mar; 13(1 Pt 1):245-7. PubMed ID: 7022832
[No Abstract] [Full Text] [Related]
15. Bone marrow transplantation for severe aplastic anemia from HLA identical siblings.
Bacigalupo A
Haematologica; 1999 Jan; 84(1):2-4. PubMed ID: 10091385
[No Abstract] [Full Text] [Related]
16. Cytotoxicity against HLA-identical sibling lymphocytes: genetic determination and independent segregation of the antigenic system involved.
Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
Transplant Proc; 1978 Mar; 10(1):67-9. PubMed ID: 345567
[No Abstract] [Full Text] [Related]
17. [Successful bone marrow transplantation in aplastic anemia in platelet-transfusion refractory status].
Nakada H; Kodo H; Matsuda S; Tsutsumi H; Horiuchi N; Sakurada S; Mouri H; Mitani S; Kanno H; Kumakawa T
Rinsho Ketsueki; 1986 Aug; 27(8):1415-20. PubMed ID: 3540362
[No Abstract] [Full Text] [Related]
18. Unique immunologic problems in human bone marrow transplant recipients.
Storb R; Tsoi MS; Witherspoon RP; Sullivan K; Lum L; Deeg HJ; Atkinson K
Transplant Proc; 1981 Sep; 13(3):1624-7. PubMed ID: 7029826
[No Abstract] [Full Text] [Related]
19. Interdisciplinary session report. Obstacles to routine transfusion support of myelosuppressive patients.
Henderson ES; Graw RG; Anderson RM; Yankee RA; Opelz G; Lalezari P; Meryman HT
Cancer Chemother Rep 3; 1973 May; 4(3):51-9. PubMed ID: 4748873
[No Abstract] [Full Text] [Related]
20. Bone marrow transplantation: correction of immune deficit in lymphopenic immunologic deficiency and correction of an immunologically induced pancytopenia.
Good RA; Meuwissen HJ; Hong R; Gatti RA
Trans Assoc Am Physicians; 1969; 82():278-85. PubMed ID: 4393025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
